Lamivudine can prevent post-transplant HBV infection

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1280, 2001-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lamivudine may prevent HBV reactivation

Inpharma, Vol. 1, Iss. 1397, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Lamivudine is effective in paediatric patients with chronic hepatitis B virus (HBV) infection

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Lamivudine may not completely prevent the vertical transmission of hepatitis B virus (HBV) to neonates

Inpharma, Vol. 1, Iss. 1336, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Interferon plus lamivudine may be effective in patients with dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infection

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Calcineurin Inhibitors and Post-Transplant Hyperlipidaemias

By Moore R.

Drug Safety, Vol. 24, Iss. 10, 2001-01 ,pp. : 755-766

Adis International

Access to resources Recommend Favorite